Tag Archives: Tasha Khan

IDI market reports modest overall growth, according to Milliman

Milliman today released the results of its latest Individual Disability Income (IDI) Market Survey. The report, in its 12th edition, measures sales trends across 15 IDI companies, representing over 90% of the market. The survey also covers recent changes in underwriting and product design, the range of views that companies have on the current profitability of their business, and the favorable and unfavorable trends that can affect the long-term profitability of the IDI market.

Key findings include:

  • Combined new IDI annualized premium from the 15 companies totaled $401 million for 2018, representing a 1.5% increase from 2017. Six of the 15 companies reported growth in new sales in 2018.
  • The top five IDI contributors to this year’s survey produced 78% of the total new annualized premium among the 15 companies, and the top 10 IDI companies produced almost 96% of the total new annualized premium.
  • The percentage of new IDI annualized premium in 2018 issued to doctors and surgeons has remained consistent, at 30%, while new premium issued to executives has been dropping since 2014, reaching 11% in 2018.
  • The employer-sponsored multi-life market continues to increase its share of new IDI annualized premium, from 42% in 2017 to 44% in 2018.

While the IDI market continues to see modest overall profit increases, high-yield premium growth has remained out of reach for most companies. Perhaps as a result, there seems to be an increased interest in branching out from the more traditional IDI market segments, with survey participants listing a wide range of growth opportunities they plan on pursuing over the coming years.

To download the entire IDI Market Survey, click here.

Individual disability income (IDI) companies see jump in combined new sales after market shake-up, according to Milliman report

Milliman has released the results of its latest Individual Disability Income (IDI) Market Survey. The report, in its 10th edition, measures sales trends across 14 IDI companies, representing 90% of the market. The survey also covers recent changes in underwriting and products, the range of views that companies have on the current profitability of their business, and the favorable and unfavorable trends that can affect the long-term profitability of the IDI market. New this year, the report also includes a section discussing companies’ progress implementing the new 2013 Valuation Table.

Key findings include:

• Combined IDI new premium from the 14 IDI companies increased in 2016 by 1.3%, compared to 5.7% in 2015. Combined IDI new premium year-to-date through June 30, 2017, increased by 9.0% over the prior year.
• New premium from the employer-sponsored multilife market exceeded 43% of total IDI new premium in 2015 and 2016.
• There is continued stability in the share of new IDI premium from doctors.
• The share of new IDI premium issued using voluntary guaranteed standard issue (GSI) underwriting was 32% and 34% in 2015 and 2016, respectively.

The decision of a major player to exit the individually sold IDI market this past year appears to be benefiting other IDI companies in 2017, as they take on a portion of those sales. We believe this is a short-term impact. In the longer term, overall IDI market growth may be constrained by the loss of one of the larger writers of IDI business.

To download the full IDI Market Survey, click here.





Self-funded short-term disability considerations

An employer’s decision regarding whether to insure its short-term disability (STD) plan depends on several factors, including the employer’s size, risk appetite, historical STD experience, desired plan design, cost considerations, and available resources. Milliman’s Tasha Khan provides more perspective in her article “Short-term disability: To be or not to be (self-funded)?

Here is an excerpt:

Employer size
STD plans typically pay a portion of lost income when an employee is disabled due to illness or injury. Usually STD covers the period of time between when sick leave/paid time off runs out and when long-term disability (LTD) benefits begin. Compared with life insurance or LTD insurance, STD is a high-frequency and low-severity benefit (i.e., there are many claims with relatively low benefit amounts, similar to most medical claims). This means that even smaller employers can quickly develop meaningful historical experience. Insurers generally consider STD claims experience to be fully credible at roughly 500 to 1,000 lives (varying by insurer and by benefit waiting period). This means that for a group with 500 or more employees, the insurance company will estimate the group’s future claims based primarily on that group’s past paid claims. This does not mean that future claims will be exactly equal to past claims; it means only that past claims are stable enough to be a useful predictor of future claims.

Due in part to this stability in claims experience over time, larger employers tend to be more likely to self-fund their STD benefits than smaller employers. For an employer with, say, 50 lives, STD claim payments could swing dramatically from year to year, making budgeting for these costs difficult. An employer with 5,000 lives, on the other hand, may expect claim payments to remain fairly stable from year to year.

Risk tolerance
Another consideration is the employer’s tolerance for risk. Even with a large and fully credible group, STD claims experience will change from year to year due to random volatility (as well as for other reasons, such as a particularly nasty flu season). With an insured plan, on the other hand, the premium to be paid is determined in advance, so the employer knows exactly what it will pay for STD coverage. The annual volatility risk is borne by the insurance company (although longer-term experience trends will ultimately be reflected in the premium rates charged by the insurer).

When choosing to self-fund, an employer should monitor its STD plan experience over time. Periodic experience studies help the employer understand how its plan is performing and make adjustments as needed. Such modifications may include revising the rates charged to employees or groups for the coverage, adjusting the liability calculations for claims that have been incurred but not yet fully paid, and reevaluating plan design and claim management practices. These types of studies may require the help of actuarial and financial resources. With an insured plan, the insurance company handles these functions….